Cytomegalovirus (CMV) Treatment market Research Report on Growth, Share, Value, Size, and Analysis | Chimerix, Clinigen Group PLC

Global Cytomegalovirus (CMV) Treatment market Size, Status, and forecast for the 2025-2032. The research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist businesses in identifying major changes in industry practices. The market report also examines the current state of the Cytomegalovirus (CMV) Treatment market industry, as well as predicted future growth, technological advancements, investment prospects, market economics, and financial data. Additionally, the report includes upstream and downstream analyses of key players, as well as global certainties and assurances. The report evaluates dynamic aspects such as forecast market information, Porter's Five Forces Analysis, sales estimates, wide product portfolio, market scenarios, and possibility studies.

The global cytomegalovirus (CMV) treatment market was valued at USD 436.8 million in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 7.10% over the forecast period.

Updated Version of Sample Report Included:
https://www.marketdigits.com/request/sample/4072

Latest Trends:

The rising prevalence of viral infections among AIDS patients, stemming from their compromised immune systems, is expected to drive the demand for cytomegalovirus drugs. Due to diminished immune function, individuals with HIV/AIDS are more susceptible to opportunistic infections, including cytomegalovirus (CMV). CMV infections can result in severe complications, especially in immunocompromised individuals like AIDS patients. Consequently, there is an increasing demand for effective CMV treatment options to manage and alleviate the impact of these infections on patient health and outcomes.
For instance, as per the World Health Organization (WHO) in November 2022, approximately 38.4 million individuals were living with HIV in 2021, comprising 36.7 million adults and 1.7 million children affected by the virus. Consequently, the high prevalence of infectious diseases among AIDS patient is expected to drive the market growth.

Major Players in Cytomegalovirus (CMV) Treatment markets are:

Chimerix, Clinigen Group PLC, F. Hoffmann-La Roche Ltd, Genentech Inc., Gilead Sciences, Inc., Merck & Co. Inc, Mylan N.V, Pfizer, Inc., Takeda Pharmaceuticals, Teva Pharmaceuticals Inc, and Thermo Fisher Scientific Inc.

Recent Development:

In September 2022, ProBioGen and the City of Hope entered in a commercial license agreement to use the AGE1.CR.pIX vaccine manufacturing platform for the Cytomegalovirus (CMV) vaccine. The commercial license agreement between ProBioGen and the City of Hope allowed the City of Hope to use the AGE1.CR.pIX platform to manufacture the CMV vaccine for clinical trials and commercial distribution. This partnership has helped company to accelerate the development and production of the CMV vaccine, which could potentially save many lives.

In November 2021, Takeda Pharmaceutical received FDA approval for the product Maribavir which is used for the treatment of adults and pediatric patients aged 12 years or older with post-transplant cytomegalovirus infection/disease that is refractory to treatment. This product approval strengthens company's overall market position.

"Connect with our team of research specialists and unlock the optimal solution for driving your business growth"

Global Cytomegalovirus (CMV) Treatment market Segmentation:

By Drug Type
Valganciclovir
Ganciclovir
Cidofovir
Foscarnet
Other drug types

By Applications
Stem cell transplantation
Organ transplantation
Congenital CMV infection
Other applications

By Route of Administration
Oral
Intravenous

By Distribution Channel
Hospital pharmacies
Retail Pharmacies
E-commerce

Know more about this report:
https://www.marketdigits.com/cytomegalovirus-treatment-market-1707902796

The following areas and countries are covered in the worldwide Cytomegalovirus (CMV) Treatment market file:

North America (US, Canada, Mexico)
Europe (Germany, France, UK, Russia, Italy)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Saudi Arabia, UAE), Egypt, Nigeria, and South Korea)

Asia Pacific is expected to grow at the fastest CAGR for the forecast period. Whereas, North America dominated the market with the largest share in 2022. According to the Cleveland Clinic article published in October 2022, the prevalence of CMV infection in the U.S. and Canada is substantial.

Detailed industry forecast-Brief Introduction to the research report:

Additional information on company participants
Customized reports and analyst assistance are available upon request.
Recent market developments and potential future growth opportunities
Personalized regional/country reports upon request
New data sources are being integrated.
Increased focus on data privacy and security
Increased collaboration and co-creation

Discover More: Visit Our Website for Additional Reports!

https://www.marketdigits.com/induced-pluripotent-stem-cells-market-1708503695

https://www.marketdigits.com/optical-genome-mapping-market-1708503695

https://www.marketdigits.com/sleep-apnea-oral-appliances-market-1708503695

https://www.marketdigits.com/antibody-therapeutics-market-1708503695

https://www.marketdigits.com/contrast-media-market-1708610489

About Us

Founded in 2015, MarketDigits Consulting & Advisory Pvt Ltd is a leading business research and consulting firm. Our mission is to empower clients by identifying emerging opportunities and driving revenue growth across industries. We specialize in providing comprehensive market insights, advanced technology solutions, and actionable strategies that support operational and strategic decision-making.

With a focus on the full value chain, our expert team delivers high-quality syndicate research reports, proprietary databases, and consulting services to help clients navigate today's competitive and dynamic business environment. At MarketDigits, we use advanced analysis to uncover profitable opportunities, enabling businesses to make smart decisions and achieve sustainable success.

Contact Us:

+1 510-730-3200 | +1 276-206-2055

sales@marketdigits.com

1248 CarMia Way Richmond

VA 23235, United States

This release was published on openPR.